Ginkgo bioworks announces date of first quarter 2024 results presentation

Presentation and q&a session scheduled for post-market on thursday, may 9, 2024 boston , may 2, 2024 /prnewswire/ -- ginkgo bioworks holdings, inc. (nyse: dna, "ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced that it plans to host a presentation and q&a session reviewing business performance for the first quarter ended march 31, 2024, on thursday, may 9, 2024, beginning at 5:30 p.m. et. the presentation details and webcast link will be available on ginkgo's investor relations website at https://investors.ginkgobioworks.com , and a replay will be made available.
DNA Ratings Summary
DNA Quant Ranking